Novel 2,3-Dihydro-1,4-Benzoxazines as Potent and Orally Bioavailable Inhibitors of Tumor-Driven Angiogenesis-Reference-Cited by-同舟云学术

Novel 2,3-Dihydro-1,4-Benzoxazines as Potent and Orally Bioavailable Inhibitors of Tumor-Driven Angiogenesis

Published:2008-02-27 Issue:6 Volume:51 Page:1695-1705
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

La Daniel S.¹,Belzile Julie¹,Bready James V.¹,Coxon Angela¹,DeMelfi Thomas¹,Doerr Nicholas¹,Estrada Juan¹,Flynn Julie C.¹,Flynn Shaun R.¹,Graceffa Russell F.¹,Harriman Shawn P.¹,Larrow Jay F.¹,Long Alexander M.¹,Martin Matthew W.¹,Morrison Michael J.¹,Patel Vinod F.¹,Roveto Philip M.¹,Wang Ling¹,Weiss Matthew M.¹,Whittington Douglas A.¹,Teffera Yohannes¹,Zhao Zhiyang¹,Polverino Anthony J.¹,Harmange Jean-Christophe¹

Affiliation:

1. Amgen Inc. Chemistry Research and Discovery, Cambridge, Massachusetts 02139, and Thousand Oaks, California 91320

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm701129j

Reference31 articles.

1. Angiogenesis in health and disease

2. Transplacental Carcinogenesis by Stilbestrol

3. The biology of VEGF and its receptors